Search

Your search keyword '"Rippe K"' showing total 232 results

Search Constraints

Start Over You searched for: Author "Rippe K" Remove constraint Author: "Rippe K"
232 results on '"Rippe K"'

Search Results

2. Pan-mutant-IDH1 inhibitor BAY1436032 is highly effective against human IDH1 mutant acute myeloid leukemia in vivo

3. Author Correction: Retrospective evaluation of whole exome and genome mutation calls in 746 cancer samples

4. Sex differences in oncogenic mutational processes

5. Analyses of non-coding somatic drivers in 2,658 cancer whole genomes

6. Pan-cancer analysis of whole genomes identifies driver rearrangements promoted by LINE-1 retrotransposition

12. TRANSCRIPTIONAL AND GENOMIC INTRA-TUMOR HETEROGENEITY DRIVES SUBCLONE SPECIFIC DRUG RESPONSES IN DIFFUSE LARGE B CELL LYMPHOMA

26. Silencing the singer: Antibioethics in Germany.

27. Biochemical characterization and mass spectrometric disulfide bond mapping of periplasmic alpha-amylase MalS of Escherichia coli.

29. Refining animal models in fracture research: seeking consensus in optimising both animal welfare and scientific validity for appropriate biomedical use

30. Pan-cancer analysis of whole genomes

31. Retrospective evaluation of whole exome and genome mutation calls in 746 cancer samples

32. Linking aberrant chromatin features in chronic lymphocytic leukemia to transcription factor networks

33. Processing of mRNA and Quality Control

34. The biological and clinical impact of deletions before and after large chromosomal gains in multiple myeloma.

35. T-bet suppresses proliferation of malignant B cells in chronic lymphocytic leukemia.

36. The Virtual Child.

37. Evolution of SARS-CoV-2 in the Rhine-Neckar/Heidelberg Region 01/2021 - 07/2023.

38. Compartments in medulloblastoma with extensive nodularity are connected through differentiation along the granular precursor lineage.

39. Hepatitis D infection induces IFN-β-mediated NK cell activation and TRAIL-dependent cytotoxicity.

40. Approaches to characterize chromatin subcompartment organization in the cell nucleus.

42. Resolving therapy resistance mechanisms in multiple myeloma by multiomics subclone analysis.

43. Nucleosome repositioning in chronic lymphocytic leukemia.

44. Resolving the spatial architecture of myeloma and its microenvironment at the single-cell level.

45. Intestinal B cells license metabolic T-cell activation in NASH microbiota/antigen-independently and contribute to fibrosis by IgA-FcR signalling.

46. Approaches for single-cell RNA sequencing across tissues and cell types.

47. The pre-existing T cell landscape determines the response to bispecific T cell engagers in multiple myeloma patients.

48. Epigenetic signals that direct cell type-specific interferon beta response in mouse cells.

49. Assessing the Phase Separation Propensity of Proteins in Living Cells Through Optodroplet Formation.

Catalog

Books, media, physical & digital resources